Updated result from the phase 2 PHAROS study: has the sustained efficacy and tolerability of encorafenib plus binimetinib been demonstrated in patients with BRAF V600E-mutant metastatic non-small-cell lung cancer?
@article{JTD109997,
author = {Kimio Yonesaka},
title = {Updated result from the phase 2 PHAROS study: has the sustained efficacy and tolerability of encorafenib plus binimetinib been demonstrated in patients with BRAF V600E-mutant metastatic non-small-cell lung cancer?},
journal = {Journal of Thoracic Disease},
volume = {17},
number = {12},
year = {2025},
keywords = {},
abstract = {},
issn = {2077-6624}, url = {https://jtd.amegroups.org/article/view/109997}
}